This is a non-promotional page intended for UK healthcare professionals only.
![Hero image. Cartoon image of person. "Over a third of CSU patients experience a high impact on quality of life¹ ask again to find out if symptoms are impacting your patients' quality of life."](/il-en/sites/pro_novartis_com_il/files/2026-05/csu_homepage_gif_banner_desktop_v3.gif "Hero image. Cartoon image of person. "Over a third of CSU patients experience a high impact on quality of life¹ ask again to find out if symptoms are impacting your patients' quality of life."")
![Hero image. Cartoon image of person. "Over a third of CSU patients experience a high impact on quality of life¹ ask again to find out if symptoms are impacting your patients' quality of life."](/il-en/sites/pro_novartis_com_il/files/2026-05/csu_homepage_gif_banner_mobile_v2.gif "Hero image. Cartoon image of person. "Over a third of CSU patients experience a high impact on quality of life¹ ask again to find out if symptoms are impacting your patients' quality of life."")
Chronic spontaneous urticaria (CSU)
Your patients may be struggling to communicate the full impact of their symptoms2,3
Real-world studies show differences in the assessment of CSU symptoms between physicians and patients. These differences may arise from intermittent CSU symptoms and unpredictable flare-ups, which may make it difficult for patients to communicate the full impact of symptoms during appointments.2,3
Doctors and patients report CSU severity differently3
Study design:3
A US cross-sectional, survey-based study (Adelphi CSU Disease Specific Programme, 2020–2021) collecting data from physicians and their adult patients with CSU via physician-completed patient record forms and matched patient questionnaires. Physician–patient matched records were used to assess agreement on disease burden and treatment satisfaction; the CSU severity alignment claims shown are from the overall matched-pair sample (n=460). This study was sponsored by Novartis.
Based on Mosnaim G, et al. 2025.3
These differences may arise from intermittent CSU symptoms and unpredictable flare-ups, making it difficult for patients to communicate the full impact of symptoms during appointments.3
Patients with CSU may feel the condition negatively affects:2
Physical comfort
Sleep
Daily activities
Work performance
Appearance
Emotional wellbeing
Find out how you can support your patients who may have difficulty communicating the full impact of their CSU symptoms
On these pages, you'll find events and videos to help you learn more about CSU and support your conversations with patients. You can also contact us and ask to speak to a Novartis medical representative about CSU.
CSU, chronic spontaneous urticaria; US, United States.
References
Balp MM, et al. J Eur Acad Dermatol Venereol 2025;39(10):1806-1817.
Maurer M, et al. Allergy 2017;72(12):2005–2016.
Mosnaim G, et al. Ann Allergy Asthma Immunol 2025;134(3):315–323.
UK | March 2026 | FA-11566689
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.